𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease

✍ Scribed by Anna Brück; Sargo Aalto; Elina Nurmi; Jörgen Bergman; Juha O. Rinne

Book ID
116780554
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
220 KB
Volume
26
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Striatal subregional 6-[18F]fluoro-L-dop
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study
✍ Anna Brück; Sargo Aalto; Elina Nurmi; Tero Vahlberg; Jörgen Bergman; Juha O. Rin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[^18^F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the

A within-subject comparison of 6-[18F]fl
A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease
✍ Catherine L. Gallagher; Bradley T. Christian; James E. Holden; Onofre T. Dejesus 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

## Abstract Progression of Parkinson's disease symptoms is imperfectly correlated with positron emission tomography biomarkers for dopamine biosynthetic pathways. The radiopharmaceutical 6‐[^18^F]fluoro‐m‐tyrosine is not a substrate for catechol‐__O__‐methyltransferase and therefore has a more favo

A follow-up study on 6-[18F]fluoro-L-dop
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen
✍ Anna Brück; Sargo Aalto; Elina Rauhala; Jörgen Bergman; Reijo Marttila; Juha O. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract Sixteen subjects with de novo Parkinson's disease (PD) underwent three 6‐[18F]fluoro‐L‐dopa (Fdopa) positron emission tomography (PET) scans during a follow‐up time of 5 years (mean ± SD 5.5 ± 0.4 years) to study the progression of striatal dopaminergic hypofunction. Throughout the stud

Rate of progression in Parkinson's disea
Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study
✍ Elina Nurmi; Hanna M. Ruottinen; Jörgen Bergman; Merja Haaparanta; Olof Solin; P 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract The aim of this study was to investigate the rate of progression in Parkinson's disease (PD) with 6‐[^18^F]fluoro‐L‐dopa (FDOPA) positron emission tomography (PET). We investigated 21 patients with PD and eight healthy controls. Ten of the patients were de novo at the time of the first